Cite
HARVARD Citation
Hwang, E. et al. (n.d.). IMMU-19. Outcomes of Pediatric Patients with High-Risk CNS Tumors Treated with Multi-tumor associated antigen specific T cell (TAA-T) therapy: the ReMIND trial. Neuro-oncology. pp. i85-i86. [Online].